• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[关于膀胱癌术前放射治疗技术的思考。基于组织学预后的治疗方案的初步结果及讨论(作者译)]

[Reflexions on techniques of preoperative radiotherapy in the treatment of carcinoma of the bladder. Initial results and discussion of a therapeutic protocol based upon histo-prognosis (author's transl)].

作者信息

Bolla M, Faure G, Chirpaz A, Martin H, Vrousos C, Revol M

出版信息

J Urol (Paris). 1981;87(9):625-9.

PMID:7334236
Abstract

Basing their indications on the histo-prognosis of Opperman and Bittard in malignant tumours of the bladder, the authors decided to irradiate before cystectomy those bladder tumours in which the histo-prognostic index indicated that it was a local disease with metastatic potential with a spontaneous life expectancy of 18 to 30 months. Radiotherapy was given spread over 23 or 27 fractions providing a total of 46 Gy. Four to 6 weeks later, cystoprostatectomy with trans-ileal cutaneous ureterostomy was performed, before chemotherapy for one year. Amongst 11 patients treated, in 6 cases the bladder was completely "sterilised" from a histological standpoint. However there was persistence of tumour in 5 bladders with an increase in the histo-prognostic index. Amongst these 11 patients, with a minimum follow-up of 18 months, there has been a pelvic recurrence in two cases and three developed fatal metastases. In the opinion of the authors, these preliminary results represent an encouragement to continue along the same lines.

摘要

作者依据奥珀曼(Opperman)和比塔尔德(Bittard)对膀胱恶性肿瘤的组织学预后判断来确定治疗指征,决定在膀胱切除术之前,对那些组织学预后指数表明为具有转移潜能的局部疾病、自然预期寿命为18至30个月的膀胱肿瘤进行放疗。放疗分23次或27次进行,总计46 Gy。4至6周后,进行膀胱前列腺切除术并做经回肠皮肤输尿管造口术,随后进行为期一年的化疗。在接受治疗的11例患者中,从组织学角度来看,6例患者的膀胱完全“清除”肿瘤。然而,5例患者的膀胱中仍有肿瘤残留,且组织学预后指数有所上升。在这11例患者中,最短随访时间为18个月,2例出现盆腔复发,3例发生致命转移。作者认为,这些初步结果为沿相同路线继续治疗提供了鼓励。

相似文献

1
[Reflexions on techniques of preoperative radiotherapy in the treatment of carcinoma of the bladder. Initial results and discussion of a therapeutic protocol based upon histo-prognosis (author's transl)].[关于膀胱癌术前放射治疗技术的思考。基于组织学预后的治疗方案的初步结果及讨论(作者译)]
J Urol (Paris). 1981;87(9):625-9.
2
[Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].[根治性膀胱切除术治疗浸润性膀胱癌的结果,特别提及根据尿流改道类型的预后因素和生活质量]
Ann Acad Med Stetin. 2000;46:217-29.
3
[Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].[仅行膀胱部分切除术治疗的34例浸润性膀胱癌分析(第1部分)]
Arch Esp Urol. 1996 May;49(4):349-64.
4
Carcinoma of the urinary bladder: long-term results of interstitial radiotherapy.膀胱癌:间质放疗的长期结果
Bull Cancer Radiother. 1994;81(1):33-40.
5
[Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].[辅助化疗治疗膀胱pT3b浸润性肿瘤的预后]
Prog Urol. 1998 Dec;8(6):1007-11.
6
[Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?].[T1G3期膀胱癌的膀胱保留或初始膀胱切除术:哪些参数有助于治疗决策?]
Aktuelle Urol. 2008 Jan;39(1):58-61; discussion 62-3. doi: 10.1055/s-2007-980147.
7
Outcome of very large superficial bladder tumours: a 10-year experience.超大型浅表性膀胱肿瘤的治疗结果:十年经验
Scand J Urol Nephrol. 2008;42(3):243-8. doi: 10.1080/00365590701832759.
8
Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy.膀胱癌合并梗阻性尿路病患者根治性膀胱切除术的肿瘤学及功能预后
J Urol. 2007 Oct;178(4 Pt 1):1206-11; discussion 1211. doi: 10.1016/j.juro.2007.05.142. Epub 2007 Aug 14.
9
An organ-sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invading bladder carcinoma.一种用于肌层浸润性膀胱癌的联合动脉内化疗和放疗的保留器官治疗方法。
Scand J Urol Nephrol. 2002;36(5):339-43. doi: 10.1080/003655902320783836.
10
Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.pTa/pT1期膀胱癌患者局部复发的危险因素。
Scand J Urol Nephrol. 2008;42(5):417-21. doi: 10.1080/00365590802016302.